Allowing Corbevax as booster for those vaccinated with Covishield, Covaxin likely to be considered by NTAGI

The Drugs Controller General of India (DCGI) on June 4 approved Corbevax as a precaution dose for those aged 18 and above. India's first indigenously-developed RBD protein subunit vaccine, Corbevax, is currently being used to inoculate children in the age group of 12 to 14 years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hFxCs9y
via IFTTT